THE GOAL OF NG MED S.R.L.SI IS TO TRANSLATE INTO THE CONTINUOUS RESEARCH OF NEW SOLUTIONS AIMED AT MAKING THE DIAGNOSIS AS RELIABLE AS POSSIBLE. IT HAS DEVELOPED OVER THE LAST THREE YEARS, THE INTEREST IN THE DEVELOPMENT OF DIAGNOSTIC KITS ORIENTED TO THE CHARACTERISATION OF PERI-TUMOR ADIPOSE TISSUE, FOR THE PURPOSES OF PROGNOSIS AND THERAPEUTIC ORIENTATION IN PATIENTS WITH MAMMARIO CANCER.THE PERICAM PROJECT REFERS TO AN IN VITRO PROCEDURE TO DETERMINE THE STAGE AND/OR SEVERITY OF THE TUMOR, TO SET THE MOST APPROPRIATE THERAPY AND/OR MONITOR THE EFFECT OF TUMOR CONTRODET THERAPY.